search
Back to results

Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children

Primary Purpose

Inhalation of Nitrous Oxide, Opioid Analgesic Adverse Reaction, Pain

Status
Completed
Phase
Phase 3
Locations
Switzerland
Study Type
Interventional
Intervention
Fentanyl intranasal
NaCl 0.9% intranasal
Sponsored by
University Children's Hospital, Zurich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Inhalation of Nitrous Oxide

Eligibility Criteria

2 Years - 16 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • indication for nitrous oxide 70% application
  • boys/girls aged 2-16 years
  • informed consent

Exclusion Criteria:

  • due to language barrier no sufficient communication possible to explain the study
  • incompatibility to Fentanyl Sintetica
  • incompatibility to morphinomimetics

Sites / Locations

  • Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Fentanyl intranasal

NaCl 0.9% intranasal

Arm Description

Fentanyl Sintetica 0.1mg/2ml: 1.5ug/kilogram intranasal= 0.03ml/kg once

NaCl 0.9% Sintetica 18mg/2ml: same dosage as fentanyl= 0.03ml/kg

Outcomes

Primary Outcome Measures

Analgesic efficacy of nitrous oxide 70% versus nitrous oxide 70% combined with fentanyl intranasal using the FLACC score
the Patient is videotaped during the painful procedure and afterwards the video is analysed using the FLACC score. Each category is scored on a 0-2 scale (5 categories) which results in a total score of 0 (no pain) -10 (severe pain).

Secondary Outcome Measures

adverse events of nitrous oxide 70% versus nitrous oxide 70% combined with fentanyl intranasal

Full Information

First Posted
July 20, 2015
Last Updated
October 25, 2017
Sponsor
University Children's Hospital, Zurich
search

1. Study Identification

Unique Protocol Identification Number
NCT02533908
Brief Title
Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children
Official Title
Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children: A Prospective, Randomized, Double-blind, Placebo-controlled, Monocentric Study
Study Type
Interventional

2. Study Status

Record Verification Date
October 2016
Overall Recruitment Status
Completed
Study Start Date
September 21, 2015 (undefined)
Primary Completion Date
October 12, 2017 (Actual)
Study Completion Date
October 12, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Children's Hospital, Zurich

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study analyzes the analgesic efficacy and adverse events of nitrous oxide 70% combined with basic analgetics compared to nitrous oxide 70% with fentanyl intranasal for analgosedation for short and painful procedures in children.
Detailed Description
Nitrous oxide 70% (N20 70%) combined with 30% oxygen meets many criteria of an ideal pain medication for procedural analgosedation in children. At the emergency department of the Children's Hospital of Zurich, Switzerland, N20 70% is regularly used for short and painful orthopaedic procedures, mostly for reduction of dislocated forearm or finger fractures. The analgesic efficacy of N20 70% still remains controversial. Therefore, all children who are eligible for N20 70% receive additionally either fentanyl or placebo intranasal and then their behavior, level of sedation and adverse events are measured during the painful procedure. The hypothesis is that a combination of N20 70% and fentanyl intranasal is not significant better than N20 70% combined with basic analgetics.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inhalation of Nitrous Oxide, Opioid Analgesic Adverse Reaction, Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
402 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fentanyl intranasal
Arm Type
Active Comparator
Arm Description
Fentanyl Sintetica 0.1mg/2ml: 1.5ug/kilogram intranasal= 0.03ml/kg once
Arm Title
NaCl 0.9% intranasal
Arm Type
Placebo Comparator
Arm Description
NaCl 0.9% Sintetica 18mg/2ml: same dosage as fentanyl= 0.03ml/kg
Intervention Type
Drug
Intervention Name(s)
Fentanyl intranasal
Other Intervention Name(s)
Fentanyl Sintetica
Intervention Description
fentanyl is applied intranasally with a MAD (mucosal atomization device) prior to the application of nitrous oxide 70% analgosedation
Intervention Type
Drug
Intervention Name(s)
NaCl 0.9% intranasal
Other Intervention Name(s)
NaCl 0.9% Sintetica
Intervention Description
Placebo is applied intranasally with a MAD (mucosal atomization device) Prior to the application of nitrous oxide 70% analgosedation
Primary Outcome Measure Information:
Title
Analgesic efficacy of nitrous oxide 70% versus nitrous oxide 70% combined with fentanyl intranasal using the FLACC score
Description
the Patient is videotaped during the painful procedure and afterwards the video is analysed using the FLACC score. Each category is scored on a 0-2 scale (5 categories) which results in a total score of 0 (no pain) -10 (severe pain).
Time Frame
up to 18 months
Secondary Outcome Measure Information:
Title
adverse events of nitrous oxide 70% versus nitrous oxide 70% combined with fentanyl intranasal
Time Frame
up to 18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: indication for nitrous oxide 70% application boys/girls aged 2-16 years informed consent Exclusion Criteria: due to language barrier no sufficient communication possible to explain the study incompatibility to Fentanyl Sintetica incompatibility to morphinomimetics
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michelle Seiler
Organizational Affiliation
University Children's Hospital of Zurich
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital
City
Zurich
ZIP/Postal Code
8032
Country
Switzerland

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
30630844
Citation
Seiler M, Staubli G, Landolt MA. Combined nitrous oxide 70% with intranasal fentanyl for procedural analgosedation in children: a prospective, randomised, double-blind, placebo-controlled trial. Emerg Med J. 2019 Mar;36(3):142-147. doi: 10.1136/emermed-2018-207892. Epub 2019 Jan 10.
Results Reference
derived

Learn more about this trial

Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in Children

We'll reach out to this number within 24 hrs